• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

玻璃体腔内注射贝伐单抗联合局部激光光凝治疗2型黄斑毛细血管扩张症合并视网膜动脉大动脉瘤

Treatment of intravitreal bevacizumab combined with focal laser photocoagulation in the case of macular telangiectasia type 2 with retinal arterial macroaneurysm.

作者信息

Demir Gökhan, Artunay Özgür, Sucu Mehmet Emin, Demircan Ali, Yaşa Dilek, Alagöz Cengiz, Öcal Mevlüt Celal

机构信息

Beyoglu Eye Training and Research Hospital, The University of Health Sciences, İstanbul, Turkey.

出版信息

Lasers Med Sci. 2019 Feb;34(1):235-238. doi: 10.1007/s10103-018-2548-z. Epub 2018 May 26.

DOI:10.1007/s10103-018-2548-z
PMID:29804166
Abstract

Macular telangiectasia type 2 (Mac Tel 2) is a bilateral disease of unknown cause with characteristic changes of the retinal vasculature. To the best of our knowledge, we could not find any reported cases of Mac Tel 2 with retinal arterial macroaneurysm (RAM). Our aim is to report a case of Mac Tel 2 with RAM.

摘要

2型黄斑毛细血管扩张症（Mac Tel 2）是一种病因不明的双侧性疾病，具有视网膜血管的特征性改变。据我们所知，我们尚未发现有任何关于Mac Tel 2合并视网膜动脉大动脉瘤（RAM）的报道病例。我们的目的是报告一例Mac Tel 2合并RAM的病例。

相似文献

1
Treatment of intravitreal bevacizumab combined with focal laser photocoagulation in the case of macular telangiectasia type 2 with retinal arterial macroaneurysm.玻璃体腔内注射贝伐单抗联合局部激光光凝治疗2型黄斑毛细血管扩张症合并视网膜动脉大动脉瘤
Lasers Med Sci. 2019 Feb;34(1):235-238. doi: 10.1007/s10103-018-2548-z. Epub 2018 May 26.
2
Treatment of intravitreal bevacizumab combined with focal laser photocoagulation in the case of macular telangiectasia type 2 with retinal arterial macroaneurysm.玻璃体腔内注射贝伐单抗联合局部激光光凝治疗2型黄斑毛细血管扩张合并视网膜动脉大动脉瘤
Lasers Med Sci. 2019 Mar;34(2):427-430. doi: 10.1007/s10103-018-2587-5. Epub 2018 Jul 19.
3
Combined treatment with intravitreal bevacizumab and laser photocoagulation for exudative maculopathy in facioscapulohumeral muscular dystrophy.玻璃体内注射贝伐单抗联合激光光凝治疗面肩肱型肌营养不良症的渗出性黄斑病变。
Ophthalmic Genet. 2017 Sep-Oct;38(5):490-493. doi: 10.1080/13816810.2017.1279183. Epub 2017 Jan 25.
4
CLINICAL FEATURES OF TREATED AND UNTREATED TYPE 1 IDIOPATHIC MACULAR TELANGIECTASIA WITHOUT THE OCCURRENCE OF SECONDARY CHOROIDAL NEOVASCULARIZATION FOLLOWED FOR 2 YEARS IN JAPANESE PATIENTS.日本患者中未经治疗和经治疗的1型特发性黄斑毛细血管扩张症的临床特征：随访2年未发生继发性脉络膜新生血管
Retina. 2018 Jan;38 Suppl 1(Suppl 1):S114-S122. doi: 10.1097/IAE.0000000000001724.
5
Subthreshold Micropulse Yellow Laser (577 nm) for Idiopathic Macular Telangiectasia Type 1 Resistant to Intravitreal Injection.阈下微脉冲黄色激光（577纳米）治疗对玻璃体内注射耐药的1型特发性黄斑毛细血管扩张症
Korean J Ophthalmol. 2020 Apr;34(2):168-169. doi: 10.3341/kjo.2019.0071.
6
Bevacizumab versus bevacizumab and macular grid photocoagulation for macular edema in eyes with non-ischemic branch retinal vein occlusion: results from a prospective randomized study.贝伐单抗对比贝伐单抗联合黄斑格栅光凝治疗非缺血性视网膜分支静脉阻塞性黄斑水肿：一项前瞻性随机研究的结果
Graefes Arch Clin Exp Ophthalmol. 2019 May;257(5):913-920. doi: 10.1007/s00417-018-04223-9. Epub 2019 Jan 4.
7
Comparison of anatomical and visual outcomes following different anti-vascular endothelial growth factor treatments in subretinal neovascular membrane secondary to type 2 proliferative macular telangiectasia.2 型增殖性黄斑毛细血管扩张症继发视网膜下新生血管膜的不同抗血管内皮生长因子治疗后解剖和视力结果的比较。
Graefes Arch Clin Exp Ophthalmol. 2020 Jan;258(1):99-106. doi: 10.1007/s00417-019-04520-x. Epub 2019 Nov 25.
8
Long-Term Follow-Up of an Atypical Case of Idiopathic Macular Telangiectasia.特发性黄斑毛细血管扩张症非典型病例的长期随访
Ophthalmic Surg Lasers Imaging Retina. 2018 Dec 1;49(12):e278-e283. doi: 10.3928/23258160-20181203-19.
9
Idiopathic Macular Telangiectasia Type 1 with Ruptured Retinal Arterial Macroaneurysm Post Intravitreal Bevacizumab.玻璃体腔注射贝伐单抗后出现视网膜动脉大动脉瘤破裂的1型特发性黄斑毛细血管扩张症
Middle East Afr J Ophthalmol. 2015 Jul-Sep;22(3):396-8. doi: 10.4103/0974-9233.159779.
10
Fluorescein Angiography Versus Optical Coherence Tomography Angiography in Macular Telangiectasia Type I Treated With Bevacizumab Therapy.在接受贝伐单抗治疗的Ⅰ型黄斑毛细血管扩张症中，荧光素血管造影与光学相干断层扫描血管造影的对比研究
Ophthalmic Surg Lasers Imaging Retina. 2017 Mar 1;48(3):263-266. doi: 10.3928/23258160-20170301-12.

引用本文的文献

1
Multimodal Imaging Characteristics of a Large Retinal Capillary Macroaneurysm in an Eye With Severe Diabetic Macular Edema: A Case Presentation and Literature Review.重度糖尿病性黄斑水肿眼中大视网膜毛细血管动脉瘤的多模态成像特征：病例报告及文献综述
Med Hypothesis Discov Innov Ophthalmol. 2020;9(1):33-37. Epub 2020 Jan 1.

本文引用的文献

1
Intravitreal ranibizumab therapy for retinal arterial macroaneurysm.玻璃体内注射雷珠单抗治疗视网膜动脉大动脉瘤。
Int J Clin Exp Med. 2015 Jul 15;8(7):11572-8. eCollection 2015.
2
Retinal arterial macroaneurysms: clinical, angiographic, and tomographic description and therapeutic management of a series of 14 cases.视网膜动脉大动脉瘤：14例系列病例的临床、血管造影及断层扫描描述与治疗管理
Eur J Ophthalmol. 2016 Jan-Feb;26(1):36-43. doi: 10.5301/ejo.5000641. Epub 2015 Jul 2.
3
Intravitreal bevacizumab for macular complications from retinal arterial macroaneurysms.
玻璃体内注射贝伐单抗治疗视网膜动脉大动脉瘤引起的黄斑并发症。
Am J Ophthalmol. 2013 Feb;155(2):287-294.e1. doi: 10.1016/j.ajo.2012.07.029. Epub 2012 Oct 27.
4
Monthly ranibizumab for nonproliferative macular telangiectasia type 2: a 12-month prospective study.每月雷珠单抗治疗非增生性 2 型黄斑毛细血管扩张症：一项 12 个月的前瞻性研究。
Am J Ophthalmol. 2011 May;151(5):876-886.e1. doi: 10.1016/j.ajo.2010.11.019. Epub 2011 Feb 19.
5
Retinal structural changes associated with retinal arterial macroaneurysm examined with optical coherence tomography.利用光学相干断层扫描技术检测与视网膜动脉大动脉瘤相关的视网膜结构变化。
Retina. 2009 Jun;29(6):782-92. doi: 10.1097/IAE.0b013e3181a2f26a.
6
The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project.国家眼科研究所黄斑毛细血管扩张症（MacTel）项目中的视觉功能问卷
Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4340-6. doi: 10.1167/iovs.08-1749. Epub 2008 Jun 27.
7
Intravitreal bevacizumab for macular edema from idiopathic juxtafoveal retinal telangiectasis.玻璃体内注射贝伐单抗治疗特发性黄斑旁视网膜毛细血管扩张症所致黄斑水肿。
Ophthalmic Surg Lasers Imaging. 2007 Mar-Apr;38(2):164-6. doi: 10.3928/15428877-20070301-15.
8
Idiopathic macular telangiectasia.特发性黄斑毛细血管扩张症
Arch Ophthalmol. 2006 Apr;124(4):450-60. doi: 10.1001/archopht.124.4.450.
9
Retinal artery macroaneurysms: clinical and fluorescein angiographic features in 34 patients.视网膜动脉大动脉瘤：34例患者的临床及荧光素血管造影特征
Eye (Lond). 2006 Sep;20(9):1011-20. doi: 10.1038/sj.eye.6702068. Epub 2005 Sep 2.
10
Lack of apparent short-term benefit of photodynamic therapy in bilateral, acquired, parafoveal telangiectasis without subretinal neovascularization.
Am J Ophthalmol. 2004 Nov;138(5):892-4. doi: 10.1016/j.ajo.2004.06.010.